Francesca Ferraro, MD, PhD, an assistant professor of medicine, has received a grant from the Damon Runyon Cancer Research Foundation to support her research on acute myeloid leukemia.
Category: Research Wire
Silva-Fisher receives grant to study multiple myeloma
Funds from the American Cancer Society will support research by Jennifer Silva-Fisher, PhD, into what drives growth and treatment resistance in multiple myeloma.
Choi, Ferraro receive grants from hematology society
Francesca Ferraro, MD, PhD, and Jaebok Choi, PhD, in the Division of Oncology will each receive $150,000 from the American Society of Hematology to study leukemia treatments.
New discovery may point to clues about how head and neck cancers spread
A research team led by Sidharth Puram, MD, identified a previously unknown population of aggressive tumor cells in difficult-to-treat head and neck cancers.
Stone awarded $3.7 million to study rare metabolic disorder
Stephen Stone, MD, was awarded a $3.7 million NIH grant to advance research into a rare metabolic disorder.
$3.4 million grant aims to study how fentanyl disrupts the brain’s locus coeruleus system
Jordan McCall, PhD, was awarded $3.4 million by the National Institute on Drug Abuse to examine how fentanyl alters the brain’s main alert and stress center and drives relapse to opioid use.
NIH grant supports study of gut microbes and blood cell production
A collaboration led by infectious diseases researcher Megan Baldridge, MD, PhD, could lead to new options for vulnerable patients to maintain healthy blood counts.
Kubanek receives One Mind Rising Star Award
The prize recognizes psychiatry researcher Jan Kubanek, PhD, for his research on using ultrasound to map and modulate the brain circuits involved in major depressive disorder.
Prize supports hunt for broad-spectrum antivirals
Infectious diseases expert Michael Diamond, MD, PhD, won a $2.5M prize to advance the development of drugs to treat debilitating chikungunya and related viruses.
New research shows promise for treating hepatitis C in pregnancy
A study led by Laura Marks, MD, and Madeline McCrary, MD, suggests oral hepatitis C treatment may be feasible during pregnancy with careful monitoring and shared decision-making.